Steroid resistant focal segmental glomerulosclerosis: effect of arterial hyalinosis on outcome: single center study

1. ADRIANA MUNTEAN AND MIHAI LUCAN. Immunosuppression in kidney transplantation. Clujul Med. 2013; 86(3): 177–180.Search in Google Scholar

2. KORBET SM. Treatment of primary FSGS in adults. J Am Soc Nephrol. 2012 Nov. 23(11):1769–76.10.1681/ASN.2012040389Search in Google Scholar

3. LAURIN LP, GASIM AM, POULTON CJ, HOGAN SL, JENNETTE JC, FALK RJ, et al. Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS. Clin J Am Soc Nephrol. 2016; 11(3):386.10.2215/CJN.07110615Search in Google Scholar

4. BURDMANN EA, ANDOH TF, YU L, BENNETT WM. Cyclosporine nephrotoxicity. Semin Nephrol. 2003; 23(5):465.10.1016/S0270-9295(03)00090-1Search in Google Scholar

5. NAIMISSA, ALEKSANDRA KUKLA AND HASSAN N. IBRAHIM. The over-exaggerated chronic nephrotoxicity of calcineurin inhibitors, Arab Journal of Urology (2012) 10, 169–174.10.1016/j.aju.2012.02.003444288726558021Search in Google Scholar

6. WILLIAMS D, HARAGSIM L. Calcineurin nephrotoxicity. Adv Chronic Kidney Dis. 2006; 13(1):47.10.1053/j.ackd.2005.11.00116412970Search in Google Scholar

7. NAESENS M, KUYPERS DR AND SARWAL M. Calcineurin Inhibitor Nephrotoxicity. Clin J Am SocNephrol. 2009; 4:481–508.10.2215/CJN.0480090819218475Search in Google Scholar

8. EKBERG H, TEDESCO-SILVA H, DEMIRBAS A, VÍTKO S, NASHAN B, GÜRKAN A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med. 2007; 357(25):2562.10.1056/NEJMoa06741118094377Search in Google Scholar

9. [GUIDELINE] Kidney Disease/Improving Global Ooutcomes. KDIGO Clinical Practice Guideline for Glomerulonephritis (GN). Kidney Int. June 2012. 2 suppl 2.Search in Google Scholar

10. SCHÖNENBERGER E, EHRICH JH, HALLER H, SCHIFFER M. The podocyte as a direct target of immunosuppressive agents. Nephrol Dial Transplant 2011: 26(1):18–24.10.1093/ndt/gfq61720937691Search in Google Scholar

11. FAUL C, DONNELLY M, MERSCHER-GOMEZ S, CHANG YH, FRANZ S, DELFGAAUW J, et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 2008: 14(9):931–938.10.1038/nm.1857410928718724379Search in Google Scholar

12. ASANUMA K, YANAGIDA-ASANUMA E, FAUL C, TOMINO Y, KIM K, MUNDEL P. Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling. Nat Cell Biol 2006: 8(5):485–491.10.1038/ncb140016622418Search in Google Scholar

13. GIPSON DS, TRACHTMAN H, KASKEL FJ, GREENE TH, RADEVA MK, GASSMAN JJ, et al. Clinical trial of focal segmental glomerulosclerosis in children and young adults. Kidney Int. 2011; 80(8):868.10.1038/ki.2011.195Search in Google Scholar

14. HOGG RJ, FRIEDMAN A, GREENE T, RADEVA M, BUDISAVLJEVIC MN, GASSMAN J, et al. Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGS. Clin J Am Soc Nephrol. 2013 Feb; 8(2):211–8.10.2215/CJN.08330812Search in Google Scholar

15. MONTANÉ B, ABITBOL C, CHANDAR J, JOSÉ STRAUSS, GASTÓN ZILLERUELO. Novel therapy of focal glomerulosclerosis with mycophenolate and angiotensin blockade. Pediatr Nephrol 2003; 18:772.10.1007/s00467-003-1174-5Search in Google Scholar

16. PONTICELLI C, RIZZONI G, EDEFONTI A, ALTIERI P, RIVOLTA E, RINALDI S, et al. A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int. 1993; 43(6):1377.10.1038/ki.1993.194Search in Google Scholar

17. NIAUDET P. Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. French Society of Pediatric Nephrology. J Pediatr. 1994; 125(6 Pt 1):981.10.1016/S0022-3476(05)82020-7Search in Google Scholar

18. LIEBERMAN KV, TEJANI A. A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children. J Am Soc Nephrol. 1996; 7(1):56.10.1681/ASN.V71568808110Search in Google Scholar

19. CHOI MJ, EUSTACE JA, GIMENEZ LF, ATTA MG, SCHEEL PJ, SOTHINATHAN R, et al. Mycophenolate mofetil treatment for primary glomerular diseases.Kidney Int. 2002; 61(3):1098.10.1046/j.1523-1755.2002.00214.x11849465Search in Google Scholar

20. DAY CJ, COCKWELL P, LIPKIN GW, SAVAGE CO, HOWIE AJ, ADU D. Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome. Nephrol Dial Transplant. 2002; 17(11):2011.10.1093/ndt/17.11.201112401863Search in Google Scholar

21. DEEGENS JK, ASSMANN KJ, STEENBERGEN EJ, HILBRANDS LB, GERLAG PGG, JANSEN JLJ, et al. Idiopathic focal segmental glomerulosclerosis: a favourable prognosis in untreated patients? Neth J Med 2005; 63:393.Search in Google Scholar

22. BANFI G, MORIGGI M, SABADINI E, FELLIN G, D’AMICO G, PONTICELLI C. The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study. Clin Nephrol 1991; 36:53.Search in Google Scholar

23. Ruggenenti P, Perico N, Mosconi L, Gaspari F, Benigni A, Amuchastegui CS, Bruzzi I, Remuzzi G. Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. Kidney Int. 1993; 43(3):706.10.1038/ki.1993.1018455370Search in Google Scholar

24. Scherrer U, Vissing SF, Morgan BJ, Rollins JA, Tindall RS, Ring S, Hanson P, Mohanty PK, Victor RG. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med. 1990; 323(11):693.10.1056/NEJM1990091332311012388667Search in Google Scholar

25. LAURIN LP, GASIM AM, DEREBAIL VK, MCGREGOR JG, KIDD JM, HOGAN SL, et al. Renal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGS. Clin J Am Soc Nephrol 2016; 11:1752.10.2215/CJN.13091215505380127445167Search in Google Scholar

26. KORBET SM. Angiotensin antagonists and steroids in the treatment of focal segmental glomerulosclerosis. Semin Nephrol 2003; 23:219.10.1053/snep.2003.5002012704582Search in Google Scholar

27. DIANA TAHERI, ALI CHEHREI, PARGOL SAMANIANPOUR, SHOHREH SADRARHAMI, AMMAR HASSANZADEH KESHTELI AND SHAHRZAD SHAHIDIE. The predictive role of histopathological findings in renal insufficiency and complete remission in a sample of Iranian adults with primary focal segmental glomerulosclerosis. J Res Med Sci. 2010 Jan-Feb; 15(1): 14–19.Search in Google Scholar

28. CATTRAN DC, WANG MM, APPEL G, MATALON A, BRIGGS W. Mycophenolate mofetil in the treatment of focal segmental glomerulosclerosis. Clin Nephrol. 2004; 62(6):405.10.5414/CNP62405Search in Google Scholar